Co-Founder and CEO
Aligning with an external organization through contract operations, supplier relationships, mergers and acquisitions goes beyond FDA regulated industries – and has existed for decades. Michael Taylor, co-founder and CEO of Schellingpoint, will share insight from multiple industries that he has gained through the Schellingpoint Alignment Optimization process, which is a sophisticated methodology based on the Nobel Prize winning algorithms of Thomas P. Schelling. Through the Alignment Optimization process, Michael has identified trends of obstacles and successful practices that gives us a greater chance to achieve “Right First Time” in our FDA regulated industries.
We explored the following questions with Michael:
- Can you explain how the Alignment Optimization process works?
- What trends of obstacles and successful practices have you observed across industries as organizations work to align on strategies, goals and expectations?
- What can the pharmaceutical and medical device industries do to prevent misalignment and maintain alignment throughout the relationship lifecycle?